Advanced search
Publication Cover
Current Medical Research and Opinion Volume 23, 2007 - Issue 3
Submit an article Journal homepage
1,371
Views
150
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting*

Eyal Meiri Bethesda Memorial Hospital, Comprehensive Cancer Care Center, Boynton Beach, FL, USACorrespondence[email protected]
,
Haresh Jhangiani Compassionate Cancer Care, Pacific Coast Hem/Onc Medical Group, Fountain Valley, CA, USA
,
James J. Vredenburgh Duke University Medical Center, Duke Brain Tumor Center, Durham, NC, USA
,
Luigi M. Barbato Solvay Pharmaceuticals, Inc., Neuroscience Department, Marietta, GA, USA
,
Frederick J. Carter Solvay Pharmaceuticals, Inc., Neuroscience Department, Marietta, GA, USA
,
Hwa-Ming Yang Solvay Pharmaceuticals, Inc., Neuroscience Department, Marietta, GA, USA
&
Vickie Baranowski Solvay Pharmaceuticals, Inc., Neuroscience Department, Marietta, GA, USA
 show all
Pages 533-543 | Accepted 05 Jan 2007, Published online: 01 Feb 2007

Citations (150)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Keti Bardhi, Shelby Coates, Christy J.W. Watson & Philip Lazarus. (2022) Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy. Expert Review of Clinical Pharmacology 15:12, pages 1443-1460.
Read now
Sven Gottschling, Oyedeji Ayonrinde, Arun Bhaskar, Marc Blockman, Oscar D’Agnone, Danial Schecter, Luis David Suárez Rodríguez, Sherry Yafai & Claude Cyr. (2020) Safety Considerations in Cannabinoid-Based Medicine. International Journal of General Medicine 13, pages 1317-1333.
Read now
Ilit Turgeman & Gil Bar-Sela. (2019) Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opinion on Investigational Drugs 28:3, pages 285-296.
Read now
Melissa E Badowski & Paa Kwesi Yanful. (2018) Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer. Therapeutics and Clinical Risk Management 14, pages 643-651.
Read now
D Alexander Oh, Neha Parikh, Varun Khurana, Christina Cognata Smith & Santosh Vetticaden. (2017) Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers. Clinical Pharmacology: Advances and Applications 9, pages 9-17.
Read now
Franjo Grotenhermen & Kirsten Müller-Vahl. (2016) Medicinal Uses of Marijuana and Cannabinoids. Critical Reviews in Plant Sciences 35:5-6, pages 378-405.
Read now
James Langworthy, Henry P Parkman & Ron Schey. (2016) Emerging strategies for the treatment of gastroparesis. Expert Review of Gastroenterology & Hepatology 10:7, pages 817-825.
Read now
Megan Brafford May & Ashley E Glode. (2016) Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics. Cancer Management and Research 8, pages 49-55.
Read now
Mark Malamood, Henry Parkman & Ron Schey. (2015) Current advances in treatment of gastroparesis. Expert Opinion on Pharmacotherapy 16:13, pages 1997-2008.
Read now
Dana Turcotte, Josée-Anne Le Dorze, Farid Esfahani, Emma Frost, Andrew Gomori & Mike Namaka. (2010) Examining the roles of cannabinoids in pain and other therapeutic indications: a review. Expert Opinion on Pharmacotherapy 11:1, pages 17-31.
Read now
Mark A Ware1, Paul Daeninck & Vincent Maida. (2008) A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. Therapeutics and Clinical Risk Management 4:1, pages 99-107.
Read now
Mellar P Davis. (2008) Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain. Expert Opinion on Investigational Drugs 17:1, pages 85-95.
Read now

Articles from other publishers (138)

Erin M. RockCheryl L. LimebeerReem SmoumRaphael MechoulamLinda A. Parker. (2023) Evaluation of Sex Differences in the Potential of Δ 9 -Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats . Cannabis and Cannabinoid Research 8:6, pages 1060-1068.
Crossref
Ahmed M. Ashour. (2023) Efficacy and safety of ondansetron for morning sickness in pregnancy: a systematic review of clinical trials. Frontiers in Pharmacology 14.
Crossref
Prateeksha Prateeksha, Vivek K. Sharma, Shiv M. Singh, Minaxi Sharma, Deepti Diwan, Abd El-Latif Hesham, Sanjay Guleria, Quang D. Nguyen, Vijai K. Gupta & Brahma N. Singh. (2023) Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy. Cancer and Metastasis Reviews 42:3, pages 823-845.
Crossref
Alissa Michel, Richard T. Lee, Elahe Salehi & Melissa K. Accordino. (2023) Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book:43.
Crossref
Zeeta Bawa, Bandana Saini, Danielle McCartney, Miguel Bedoya-Pérez, Andrew J. McLachlan & Iain S. McGregor. (2022) A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis. International Journal of Clinical Pharmacy 45:2, pages 375-386.
Crossref
César Eduardo Fernandes, José Eduardo Lutaif Dolci, Leonardo Sobral Navarro, Marcelo Allevato, Clóvis Francisco Constantino, Rodrigo Pastor Alves Pereira, Carlos Roberto de Mello Rieder, Flávia Torino, Wanderley Marques Bernardo & Antônio Geraldo da Silva. (2023) Cannabis products: medical use. Revista da Associação Médica Brasileira 69:3, pages 358-364.
Crossref
Mohammad Bashashati & Ron Schey. 2023. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions 391 405 .
Ana I Fraguas-Sánchez & Ana I. Torres-Suárez. 2023. Current Applications, Approaches, and Potential Perspectives for Hemp. Current Applications, Approaches, and Potential Perspectives for Hemp 407 445 .
Eric E. Kaczor, Kevin Greene, Jennifer Zacharia, Laura Tormoehlen, Mark Neavyn & Stephanie Carreiro. (2022) Correction to: The Potential Proconvulsant Effects of Cannabis: a Scoping Review. Journal of Medical Toxicology 19:1, pages 54-60.
Crossref
Bryony Alderman, David Hui, Sandip Mukhopadhyay, Carole Bouleuc, Amy A. Case, Koji Amano, Gregory B. Crawford, Giulia de Feo, Andrea Sbrana, Kimberson Tanco, Josephine To, Jessica Garsed & Mellar Davis. (2022) Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Supportive Care in Cancer 31:1.
Crossref
Hans-Georg Kress & Birgit Kraft. 2023. Schmerzbehandlung in der Palliativmedizin. Schmerzbehandlung in der Palliativmedizin 125 137 .
Popi Kasvis, Michelle Canac-Marquis, Saro Aprikian, MariaLuisa Vigano & Antonio Vigano. (2022) Sex differences exist in the perceived relief of cancer symptoms with medical cannabis: results from the Quebec Cannabis Registry. Supportive Care in Cancer 30:10, pages 7863-7871.
Crossref
Albert Garcia-Romeu, Joshua Elmore, Rhiannon E. Mayhugh, Nicolas J. Schlienz, Erin L. Martin, Justin C. Strickland, Marcel Bonn-Miller, Heather Jackson & Ryan Vandrey. (2022) Online survey of medicinal cannabis users: Qualitative analysis of patient-level data. Frontiers in Pharmacology 13.
Crossref
Ainhoa Bilbao & Rainer Spanagel. (2022) Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Medicine 20:1.
Crossref
Eric E. Kaczor, Kevin Greene, Jennifer Zacharia, Laura Tormoehlen, Mark Neavyn & Stephanie Carreiro. (2022) The Potential Proconvulsant Effects of Cannabis: a Scoping Review. Journal of Medical Toxicology 18:3, pages 223-234.
Crossref
Ana Bagues, Yolanda López-Tofiño, Álvaro Llorente-Berzal & Raquel Abalo. (2022) Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models. Behavioural Pharmacology 33:2&3, pages 105-129.
Crossref
Matthias Karst. (2022) Cannabis: Was Onkologen zu Indikation, Evidenz und Wirkung wissen sollten. InFo Hämatologie + Onkologie 25:4, pages 38-49.
Crossref
Recardia Schoeman, Amy de la Harpe, Natasha Beukes & Carminita L. Frost. (2022) Cannabis with breast cancer treatment: propitious or pernicious?. 3 Biotech 12:2.
Crossref
Kyla N. Price, Alyssa M. Thompson & Vivian Y. Shi. 2022. A Comprehensive Guide to Hidradenitis Suppurativa. A Comprehensive Guide to Hidradenitis Suppurativa 273 282 .
Jørn Herrstedt, Sanne Lindberg & Peter Clausager Petersen. (2021) Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes. Drugs & Aging 39:1, pages 1-21.
Crossref
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckPaul Daeninck, Rachel Rudney & Mellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care 129 152 .
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Vanessa Piechotta, Anne Adams, Madhuri Haque, Benjamin Scheckel, Nina Kreuzberger, Ina Monsef, Karin Jordan, Kathrin Kuhr & Nicole Skoetz. (2021) Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Rainer Spanagel & Ainhoa Bilbao. (2021) Approved cannabinoids for medical purposes – Comparative systematic review and meta-analysis for sleep and appetite. Neuropharmacology 196, pages 108680.
Crossref
Alexandre H. Watanabe, Leenhapong Navaravong, Thitipong Sirilak, Ratthanon Prasitwarachot, Surakit Nathisuwan, Robert L. PageIIII & Nathorn Chaiyakunapruk. (2021) A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids. Journal of the American Pharmacists Association 61:5, pages e1-e13.
Crossref
Amelia Dahlén, Mahdi Zarei, Adam Melgoza, Mahendra Wagle & Su Guo. (2021) THC-induced behavioral stereotypy in zebrafish as a model of psychosis-like behavior. Scientific Reports 11:1.
Crossref
Julia Fehniger, Allison L. Brodsky, Arum Kim & Bhavana Pothuri. (2021) Medical marijuana utilization in gynecologic cancer patients. Gynecologic Oncology Reports 37, pages 100820.
Crossref
Lindsey Sawtelle & Lisa M. Holle. (2020) Use of Cannabis and Cannabinoids in Patients With Cancer. Annals of Pharmacotherapy 55:7, pages 870-890.
Crossref
Kaleb Bogale, Wesley Raup-Konsavage, Shannon Dalessio, Kent Vrana & Matthew D. Coates. (2021) Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Medical Cannabis and Cannabinoids 4:2, pages 97-106.
Crossref
Joshua G. Henry, Gregory Shoemaker, Jennifer M. Prieto, Many Beth Hannon & Joseph J. Wakshlag. (2021) The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis. Veterinary and Comparative Oncology 19:2, pages 253-265.
Crossref
Weixia Zhong, Omar Shahbaz, Garrett Teskey, Abrianna Beever, Nala Kachour, Vishwanath Venketaraman & Nissar A. Darmani. (2021) Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems. International Journal of Molecular Sciences 22:11, pages 5797.
Crossref
Latha Velayudhan, Katie McGoohan & Sagnik Bhattacharyya. (2021) Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLOS Medicine 18:3, pages e1003524.
Crossref
Mahmoud Abu-Amna, Talal Salti, Mona Khoury, Idan Cohen & Gil Bar-Sela. (2021) Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?. Current Treatment Options in Oncology 22:2.
Crossref
Samridhi Lal, Anusmita Shekher, Puneet, Acharan S. Narula, Heidi Abrahamse & Subash C. Gupta. (2021) Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities. Pharmacological Research 163, pages 105302.
Crossref
María Soledad Belingeri & Laura Romina Caltana. 2021. Discovery and Development of Anti-Breast Cancer Agents from Natural Products. Discovery and Development of Anti-Breast Cancer Agents from Natural Products 103 122 .
Wendy Suhre, Vikas O’Reilly-Shah & Wil Van Cleve. (2020) Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: a retrospective machine-learning causal analysis. BMC Anesthesiology 20:1.
Crossref
Shannon Inglet, Bradly Winter, Sarah E. Yost, Sophia Entringer, Anh Lian, Meryl Biksacky, Renee D. Pitt & Whitney Mortensen. (2020) Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature. Annals of Pharmacotherapy 54:11, pages 1109-1143.
Crossref
Steven James. 2020. A Clinician's Guide to Cannabinoid Science. A Clinician's Guide to Cannabinoid Science 41 54 .
Ece Unal, Brigitte Anderson, Andrew Helber & John H. Marks. (2020) Cannabinoids. Journal of Clinical Gastroenterology 54:9, pages 769-788.
Crossref
N. Naoun. (2020) Cannabis et cancer : à la veille de l’expérimentation française du cannabis thérapeutique, de quelles données disposons-nous sur ses propriétés thérapeutiques et ses dangers ?. Psycho-Oncologie 14:3, pages 97-105.
Crossref
Lisa M. Wooldridge, Lipin Ji, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Jack Bergman & Brian D. Kangas. (2020) Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics 374:3, pages 462-468.
Crossref
Rudolph M Navari & Eric J Roeland. (2020) Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studies. Future Oncology 16:24, pages 1863-1872.
Crossref
Henry P. Parkman, Emily P. Sharkey, Linda A. Nguyen, Katherine P. Yates, Thomas L. Abell, William L. Hasler, William Snape, John Clarke, Ron Schey, Kenneth L. Koch, Braden Kuo, Richard W. McCallum, Irene Sarosiek, Madhusudan Grover, Gianrico Farrugia, James Tonascia & Pankaj J. Pasricha. (2019) Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit. Digestive Diseases and Sciences 65:8, pages 2311-2320.
Crossref
Ronald Chow, Crystal Valdez, Natalie Chow, Daniel Zhang, James Im, Emily Sodhi & Michael Lock. (2020) Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis. Supportive Care in Cancer 28:5, pages 2095-2103.
Crossref
Jennifer H. Martin, Wayne Hall, Mary‐Ann Fitzcharles, Laura Borgelt & Jose Crippa. (2020) Ensuring access to safe, effective, and affordable cannabis‐based medicines. British Journal of Clinical Pharmacology 86:4, pages 630-634.
Crossref
Danny J. Avalos, Alejandro Robles, Il J. Paik, Melissa Hershman & Richard W. McCallum. 2020. Clinical and Basic Neurogastroenterology and Motility. Clinical and Basic Neurogastroenterology and Motility 293 304 .
Matthew Chung & Salahadin Abdi. 2020. Cannabis in Medicine. Cannabis in Medicine 325 343 .
Patrick Tapley & Suzanne Kellett. (2019) Cannabis-based medicines and the perioperative physician. Perioperative Medicine 8:1.
Crossref
Wessam H. Abd-Elsalam, Muhammad A. Alsherbiny, Janice Y. Kung, David W. Pate & Raimar Löbenberg. (2019) LC–MS/MS quantitation of phytocannabinoids and their metabolites in biological matrices. Talanta 204, pages 846-867.
Crossref
Sean B. Ogden, Michael S. Malamas, Alexandros Makriyannis & Lisa A. Eckel. (2019) The novel cannabinoid CB 1 receptor agonist AM11101 increases food intake in female rats . British Journal of Pharmacology 176:20, pages 3972-3982.
Crossref
Kathleen A. Russell. (2019) Caring for Patients Using Medical Marijuana. Journal of Nursing Regulation 10:3, pages 47-61.
Crossref
Marcel O. Bonn-MillerCharles V. PollackJr.Jr., David CasarettRichard DartMahmoud ElSohlyLarry GoodManuel GuzmánLumír HanušKevin P. HillMarilyn A. HuestisEric MarshSusan SisleyNancy SkinnerJudith SpahrRyan VandreyEugene ViscusiMark A. WareDonald Abrams. (2019) Priority Considerations for Medicinal Cannabis-Related Research. Cannabis and Cannabinoid Research 4:3, pages 139-157.
Crossref
Danielle Brown, Michael Watson & Janet Schloss. (2019) Pharmacological evidence of medicinal cannabis in oncology: a systematic review. Supportive Care in Cancer 27:9, pages 3195-3207.
Crossref
R.A. Williams & D.W. Williams. 2019. Industrial Hemp as a Modern Commodity Crop. Industrial Hemp as a Modern Commodity Crop 73 91 .
Donald I. Abrams. (2019) Should Oncologists Recommend Cannabis?. Current Treatment Options in Oncology 20:7.
Crossref
Charles Robert. 2019. Entretien motivationnel en soins infirmiers. Entretien motivationnel en soins infirmiers 289 293 .
S. Lejczak, H. Rousselot, P. Di Patrizio & M. Debouverie. (2019) Dronabinol use in France between 2004 and 2017. Revue Neurologique 175:5, pages 298-304.
Crossref
Toni Leigh Mortimer, Tom Mabin & Anna-Mart Engelbrecht. (2019) Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting. Future Oncology 15:9, pages 1035-1049.
Crossref
Amber S. Kleckner, Ian R. Kleckner, Charles S. Kamen, Mohamedtaki A. Tejani, Michelle C. Janelsins, Gary R. Morrow & Luke J. Peppone. (2019) Opportunities for cannabis in supportive care in cancer. Therapeutic Advances in Medical Oncology 11, pages 175883591986636.
Crossref
Grant Steele, Tom Arneson & Dylan Zylla. (2019) A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety. Current Oncology Reports 21:1.
Crossref
Eva Hoch, Miriam Schneider, Rupert von Keller, Udo Bonnet, Peter Falkai, Alkomiet Hasan, Winfried Häuser, Burkhard Hinz, Luise Jakob, Johannes Kabisch, Ludwig Kraus, Dominik Niemann, Frank Petzke, Oliver Pogarell, Ulrich Preuss, Lukas Radbruch, Nina Sarubin, Kathrin Schacherbauer, Michael Schäfer, Martin Storr & Chris Maria Friemel. 2019. Cannabis: Potenzial und Risiko. Cannabis: Potenzial und Risiko 265 426 .
Bertrand Behm, Carlos Fernandez & Mellar P. Davis. 2019. Textbook of Palliative Care. Textbook of Palliative Care 239 257 .
Rudolph M. Navari. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice 1007 1045 .
Muhammad Alsherbiny & Chun Li. (2018) Medicinal Cannabis—Potential Drug Interactions. Medicines 6:1, pages 3.
Crossref
Eric P. Baron, Philippe Lucas, Joshua Eades & Olivia Hogue. (2018) Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. The Journal of Headache and Pain 19:1.
Crossref
Torri D. Metz & Laura M. Borgelt. (2018) Marijuana Use in Pregnancy and While Breastfeeding. Obstetrics & Gynecology 132:5, pages 1198-1210.
Crossref
Ana Isabel Fraguas-Sánchez & Ana Isabel Torres-Suárez. (2018) Medical Use of Cannabinoids. Drugs 78:16, pages 1665-1703.
Crossref
Dylan ZyllaGrant SteeleJustin EklundJeanne MettnerTom Arneson. (2018) Oncology Clinicians and the Minnesota Medical Cannabis Program: A Survey on Medical Cannabis Practice Patterns, Barriers to Enrollment, and Educational Needs. Cannabis and Cannabinoid Research 3:1, pages 195-202.
Crossref
Glen Bayer. (2018) The Case Against. Journal of Pharmacy Practice and Research 48:5, pages 473-475.
Crossref
Vincenzo Di Marzo. (2018) New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery 17:9, pages 623-639.
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
Jose M. Garcia & Tatyana A. Shamliyan. (2018) Cannabinoids in Patients with Nausea and Vomiting Associated with Malignancy and Its Treatments. The American Journal of Medicine 131:7, pages 755-759.e2.
Crossref
. (2018) Appendix C: References (Part I). Journal of Nursing Regulation 9:2, pages S52-S58.
Crossref
. (2018) Appendix B: Quality Research, Evidence of Effectiveness of Medical Cannabis. Journal of Nursing Regulation 9:2, pages S47-S51.
Crossref
. (2018) Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 9:2, pages S6-S21.
Crossref
Donald I. Abrams. (2018) The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European Journal of Internal Medicine 49, pages 7-11.
Crossref
Bertrand Behm, Carlos Fernandez & Mellar P. Davis. 2018. Textbook of Palliative Care. Textbook of Palliative Care 1 19 .
Steven A. Pergam, Maresa C. Woodfield, Christine M. Lee, Guang-Shing Cheng, Kelsey K. Baker, Sara R. Marquis & Jesse R. Fann. (2017) Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 123:22, pages 4488-4497.
Crossref
Rudolf LikarGerhard Nahler. (2017) The use of cannabis in supportive care and treatment of brain tumor. Neuro-Oncology Practice 4:3, pages 151-160.
Crossref
Sanda Vladimir‐Knežević, Biljana Blažeković, Maja Bival Štefan & Marija Kindl. 2017. Natural Products and Cancer Drug Discovery. Natural Products and Cancer Drug Discovery.
Yan LuHope D. Anderson. (2017) Cannabinoid signaling in health and disease. Canadian Journal of Physiology and Pharmacology 95:4, pages 311-327.
Crossref
Hemant Goyal, Umesh Singla, Urvashi Gupta & Elizabeth May. (2017) Role of cannabis in digestive disorders. European Journal of Gastroenterology & Hepatology 29:2, pages 135-143.
Crossref
G. Vera, J. Fichna & R. Abalo. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies 947 957 .
D. Zalman & G. Bar-Sela. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies 859 868 .
Craig M. Alpert, Michael A. Smith, Scott L. Hummel & Ellen K. Hummel. (2016) Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Failure Reviews 22:1, pages 25-39.
Crossref
William L. Hasler. 2017. Nausea and Vomiting. Nausea and Vomiting 119 137 .
Erin M. RockMartin A. StichtCheryl L. LimebeerLinda A. Parker. (2016) Cannabinoid Regulation of Acute and Anticipatory Nausea. Cannabis and Cannabinoid Research 1:1, pages 113-121.
Crossref
Zachary Wilmer Reichenbach & Ron Schey. (2016) Cannabinoids and GI Disorders: Endogenous and Exogenous. Current Treatment Options in Gastroenterology 14:4, pages 461-477.
Crossref
Jayesh R. Parmar, Benjamin D. Forrest & Robert A. Freeman. (2016) Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in Social and Administrative Pharmacy 12:4, pages 638-654.
Crossref
Rudolph M. Navari & Matti Aapro. (2016) Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting. New England Journal of Medicine 374:14, pages 1356-1367.
Crossref
Mathieu Côté, Mathieu Trudel, Changshu Wang & André Fortin. (2015) Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers. Annals of Otology, Rhinology & Laryngology 125:4, pages 317-324.
Crossref
Rudolph M. Navari. 2016. Management of Chemotherapy-Induced Nausea and Vomiting. Management of Chemotherapy-Induced Nausea and Vomiting 163 176 .
Katherine A Belendiuk, Lisa L Baldini & Marcel O Bonn-Miller. (2015) Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addiction Science & Clinical Practice 10:1.
Crossref
Lesley A Smith, Fredric Azariah, Verna TC Lavender, Nicola S Stoner & Silvana Bettiol. (2015) Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews 2021:11.
Crossref
Joshua J. Elder & Holly M. Knoderer. (2015) Characterization of Dronabinol Usage in a Pediatric Oncology Population. The Journal of Pediatric Pharmacology and Therapeutics 20:6, pages 462-467.
Crossref
Eric P. Baron. (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …. Headache: The Journal of Head and Face Pain 55:6, pages 885-916.
Crossref
Matthew W. Elmes, Martin Kaczocha, William T. Berger, KwanNok Leung, Brian P. Ralph, Liqun Wang, Joseph M. Sweeney, Jeremy T. Miyauchi, Stella E. Tsirka, Iwao Ojima & Dale G. Deutsch. (2015) Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD). Journal of Biological Chemistry 290:14, pages 8711-8721.
Crossref
Joan L. Kramer. (2015) Medical marijuana for cancer. CA: A Cancer Journal for Clinicians 65:2, pages 109-122.
Crossref
Sattar Ostadhadi, Mahdieh Rahmatollahi, Ahmad-Reza Dehpour & Reza Rahimian. (2015) Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review. Phytotherapy Research 29:3, pages 332-338.
Crossref
Sarah L. Hernandez, Inna Sheyner, Karen T. Stover & Jonathan T. Stewart. (2013) Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis. American Journal of Hospice and Palliative Medicine® 32:1, pages 5-7.
Crossref
Mark E Gerich, Robert W Isfort, Bryan Brimhall & Corey A Siegel. (2015) Medical Marijuana for Digestive Disorders: High Time to Prescribe?. American Journal of Gastroenterology 110:2, pages 208-214.
Crossref
Zubair Malik, Daniel Baik & Ron Schey. (2015) The Role of Cannabinoids in Regulation of Nausea and Vomiting, and Visceral Pain. Current Gastroenterology Reports 17:2.
Crossref
Praveen Ranganath, Lawrence Einhorn & Costantine Albany. (2015) Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy. BioMed Research International 2015, pages 1-8.
Crossref
Martin A. Sticht, Erin M. Rock, Cheryl L. Limebeer & Linda A. Parker. 2015. Endocannabinoids. Endocannabinoids 127 162 .
Thaiana Aragão Santana, Damila Cristina Trufelli, Leandro Luongo de Matos, Felipe Melo Cruz & Auro Del Giglio. (2014) Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting. Supportive Care in Cancer 23:1, pages 213-222.
Crossref
Rudolph M. Navari. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice 779 804 .
Erin M. Rock, Cheryl L. Limebeer & Linda A. Parker. (2014) Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Experimental Brain Research 232:8, pages 2511-2534.
Crossref
Y. Nasser, M. Bashashati & C. N. Andrews. (2014) Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher”. Neurogastroenterology & Motility 26:4, pages 447-454.
Crossref
Álvaro Sanz, Maku Zudaire, Begoña Morejón, Virginia de la Cruz, Itziar Gardeazabal, José María López-Picazo, María Luisa del Valle & Carlos Centeno. (2014) Cómo responder al paciente con cáncer avanzado que nos plantea el uso de cannabis como tratamiento sintomático. Medicina Paliativa 21:2, pages 79-88.
Crossref
Keith A. Sharkey, Nissar A. Darmani & Linda A. Parker. (2014) Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. European Journal of Pharmacology 722, pages 134-146.
Crossref
Nissar A. Darmani, Seetha Chebolu, Weixia Zhong, Chung Trinh, Bryan McClanahan & Rajivinder S. Brar. (2014) Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva). European Journal of Pharmacology 722, pages 147-155.
Crossref
. (2013) Minimize and manage the occurrence of chemotherapy-induced nausea and vomiting with a carefully selected prophylactic regimen. Drugs & Therapy Perspectives 29:7, pages 210-214.
Crossref
Alexandra Thielmann & Paul J Daeninck. (2013) Medical marijuana in cancer: harmful or harm reduction?. Clinical Practice 10:3, pages 371-381.
Crossref
D Bolognini, EM Rock, NL Cluny, MG Cascio, CL Limebeer, M Duncan, CG Stott, FA Javid, LA Parker & RG Pertwee. (2013) Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT 1A receptor activation . British Journal of Pharmacology 168:6, pages 1456-1470.
Crossref
Rudolph M. Navari. (2013) Management of Chemotherapy-Induced Nausea and Vomiting. Drugs 73:3, pages 249-262.
Crossref
Franjo Grotenhermen & Kirsten Müller-Vahl. (2012) The Therapeutic Potential of Cannabis and Cannabinoids. Deutsches Ärzteblatt international.
Crossref
Daniel W. Bowles, Cindy L. O’Bryant, D. Ross Camidge & Antonio Jimeno. (2012) The intersection between cannabis and cancer in the United States. Critical Reviews in Oncology/Hematology 83:1, pages 1-10.
Crossref
J. -B. Rey, V. Launay-Vacher, F. Scotté, I. Krakowski & M. Aapro. (2012) Mise à jour des recommandations de la MASCC et de l’ESMO pour la prévention des nausées et vomissements chimio- et radio-induits: résultats de la conférence de consensus de PérouseGuideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Oncologie 14:5, pages 329-342.
Crossref
Rudolph M. Navari. (2012) Treatment of chemotherapy-induced nausea. Community Oncology 9:1, pages 20-26.
Crossref
Hans Georg Kress & Birgit Kraft. 2012. Schmerzbehandlung in der Palliativmedizin. Schmerzbehandlung in der Palliativmedizin 99 108 .
Linda A Parker, Erin M Rock & Cheryl L Limebeer. (2011) Regulation of nausea and vomiting by cannabinoids. British Journal of Pharmacology 163:7, pages 1411-1422.
Crossref
Steven M. Grunberg, David Warr, Richard J. Gralla, Bernardo L. Rapoport, Paul J. Hesketh, Karin Jordan & Birgitte T. Espersen. (2010) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art. Supportive Care in Cancer 19:S1, pages 43-47.
Crossref
Eliezer Soto & Ann M. Berger. 2011. Palliative Care. Palliative Care 115 128 .
N. Percie Du Sert, W.-S. V. Ho, J. A. Rudd & P. L. R. Andrews. (2010) Cannabinoid-induced reduction in antral pacemaker frequency: a telemetric study in the ferret. Neurogastroenterology & Motility 22:11, pages 1257-e324.
Crossref
Marta Duran, Eulàlia Pérez, Sergio Abanades, Xavier Vidal, Cristina Saura, Margarita Majem, Edurne Arriola, Manel Rabanal, Antoni Pastor, Magí Farré, Neus Rams, Joan‐Ramon Laporte & Dolors Capellà. (2010) Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology 70:5, pages 656-663.
Crossref
Nissar A. Darmani. (2010) Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting. Pharmaceuticals 3:9, pages 2930-2955.
Crossref
F. Roila, J. Herrstedt, M. Aapro, R.J. Gralla, L.H. Einhorn, E. Ballatori, E. Bria, R.A. Clark-Snow, B.T. Espersen, P. Feyer, S.M. Grunberg, P.J. Hesketh, K. Jordan, M.G. Kris, E. Maranzano, A. Molassiotis, G. Morrow, I. Olver, B.L. Rapoport, C. Rittenberg, M. Saito, M. Tonato & D. Warr. (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Annals of Oncology 21, pages v232-v243.
Crossref
Arno Hazekamp, Justin T. Fischedick, Mónica Llano Díez, Andrea Lubbe & Renee L. Ruhaak. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II 1033 1084 .
Birgit Kraft & H. G. Kress. (2009) Cannabinoids in pain and palliative care medicine – hope or dope?. memo - Magazine of European Medical Oncology 2:3, pages 166-172.
Crossref
Nissar A. Darmani & Andrew P. Ray. (2009) Evidence for a Re-Evaluation of the Neurochemical and Anatomical Bases of Chemotherapy-Induced Vomiting. Chemical Reviews 109:7, pages 3158-3199.
Crossref
Fernando Caudevilla Gálligo & Antonio Cabrera Majada. (2009) Novedades sobre el cannabis. FMC - Formación Médica Continuada en Atención Primaria 16:4, pages 204-212.
Crossref
Simona Pisanti, Anna Maria Malfitano, Claudia Grimaldi, Antonietta Santoro, Patrizia Gazzerro, Chiara Laezza & Maurizio Bifulco. (2009) Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Best Practice & Research Clinical Endocrinology & Metabolism 23:1, pages 117-131.
Crossref
Yaozhi Wang, Andrew P. Ray, Bryan A. McClanahan & Nissar A. Darmani. (2009) The antiemetic interaction of Δ9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew. Pharmacology Biochemistry and Behavior 91:3, pages 367-373.
Crossref
Tara L. Lin*David S. Ettinger. 2009. Supportive Care in Cancer Therapy. Supportive Care in Cancer Therapy 179 192 .
Rita Lenk & Rudolf Likar. (2008) Cannabinoide in der MedizinCannabinoids in Medicine. Wiener Medizinische Wochenschrift 158:23-24, pages 668-673.
Crossref
Laurence Bonhomme-Faivre, Amine Benyamina, Michel Reynaud, Robert Farinotti & Chadi Abbara. (2008) Disposition of Δ 9 tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein . Addiction Biology 13:3-4, pages 295-300.
Crossref
Lisa Lohr. (2008) Chemotherapy-Induced Nausea and Vomiting. The Cancer Journal 14:2, pages 85-93.
Crossref
Zhongyi Zhang, Yong Wang, Yan Wang & Feng Xu. (2008) Antiemetic placebo: Reduce adverse drug interactions between chemotherapeutic agents and antiemetic drugs in cancer patients. Medical Hypotheses 70:3, pages 551-555.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.